M&G PLC Neurocrine Biosciences Inc Transaction History
M&G PLC
- $17.1 Billion
- Q3 2025
A detailed history of M&G PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, M&G PLC holds 83,686 shares of NBIX stock, worth $12.3 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
83,686Holding current value
$12.3 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
702Shares Held
104MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.09 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$1.43 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$820 Million0.42% of portfolio
-
Jpmorgan Chase & CO New York, NY4.73MShares$697 Million0.04% of portfolio
-
State Street Corp Boston, MA4.47MShares$658 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...